Pages that link to "Q83180242"

The following pages link to A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas (Q83180242):

Displaying 17 items.

• Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges (Q33753722) (← links)
• Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience. (Q34527573) (← links)
• Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. (Q36378279) (← links)
• Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience (Q37242570) (← links)
• A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. (Q37566349) (← links)
• Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival (Q37732871) (← links)
• Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. (Q37763010) (← links)
• Efficacy and tolerability of weekly low‐dose cisplatin concurrent with radiotherapy in head and neck cancer patients (Q37925136) (← links)
• Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries (Q39644728) (← links)
• A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer (Q83462593) (← links)
• Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin (Q84843847) (← links)
• Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysis (Q88795045) (← links)
• Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma (Q90053621) (← links)
• Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck (Q91620241) (← links)
• Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis (Q92141565) (← links)
• Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy (Q92172734) (← links)
• Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy (Q92637586) (← links)